Kanvas Biosciences is a spatial biology company building the world’s first microbiome drug screening, discovery and manufacturing platform to accelerate the development of next generation live biotherapeutics. With an unparalleled ability to spatially map the microbiome and profile host gene expression and the unique ability to manufacture complex consortia containing hundreds of members that can restore microbiome health, Kanvas is uniquely positioned to develop novel therapeutics that can significantly improve the lives of all patients living with microbiome-associated diseases.